MACREGEN, INC. v. BURNETTE

District Court, M.D. North Carolina·Decided June 30, 2021·No. 1:19-cv-00591·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF NORTH CAROLINA

) MACREGEN, INC., ) ) Plaintiff, v. ) 1:19CV591 )

W. NEAL BURNETTE III, ) )

Defendant. ) ) MEMORANDUM OPINION AND ORDER This matter is before the Court on Plaintiff MacRegen, Inc.’s Motion to Dismiss Defendant’s Counterclaims [Doc. #24]. Defendant W. Neal Burnette III (“Burnette”) alleges that he “provided valuable and specialized services to MacRegen without receiving due compensation” and asserts claims for breach of contract, quantum meruit, negligent misrepresentation, and fraudulent misrepresentation. (See generally Countercls. [Doc. #19].) MacRegen, Inc. (“MacRegen”) challenges the sufficiency of the allegations of each claim and argues that the economic loss rule bars the tort claims. (See generally Mem. of Law in Supp. of Pl.’s Mot. to Dismiss Def.’s Countercls. (“Mem. in Supp.”) [Doc. #25].) For the reasons explained below, the motion is granted. I. For purposes of a motion to dismiss, the facts alleged in the counterclaims are construed in the light most favorable to the counterclaim-plaintiff and all reasonable inferences are drawn in his favor. See U.S. ex rel. Oberg v. Pa. Higher Educ. Assistance Agency, 745 F.3d 131, 136 (4th Cir. 2014). “Burnette is a distinguished executive and researcher in the pharmaceutical industry, academia, and the United States armed forces, amassing decades of experience and accolades.” (Countercls. ¶ 7.) “MacRegen is an early-stage biopharmaceutical

company developing treatments for ophthalmological diseases including macular degeneration.” (Id. ¶ 9.) MacRegen recruited Burnette to work as a consultant, and he began work in 2014. (Id. ¶¶ 8, 10-11.) Not yet having executed a written consulting agreement (“Consulting Agreement”), Burnette did so in July 2015. (Id. ¶¶ 11-12.) This Consulting Agreement included an exhibit entitled “Project

Assignment #___ Under Consulting Agreement” (“Project Assignment”) according to which Burnette was to “perform certain services in exchange for 150,000 common shares of MacRegen’s stock”. (Id. ¶¶ 12, 14.) These services listed in the Project Assignment “merely reflected work that he had already done” in the preceding year. (Id. ¶ 24.) After Burnette performed the services in the Project Assignment, he was

given new assignments that were more substantive and time-intensive. (Id. ¶ 15.) “Among other tasks, Dr. Burnette developed business plans, created and revised executive summaries and presentations for prospective investors, reviewed scientific research and data, devised research and development strategy, evaluated scientific agreements and patents, conducted business and scientific meetings, and

provided guidance and oversight for MacRegen’s executives” as “MacRegen sought to use Dr. Burnette to assist in raising investment capital.” (Id. ¶¶ 16, 27.) These new project assignments were not in writing, but Burnette “was told by representatives of MacRegen that, with each new task and assignment, he would be compensated in accordance with the time and skill these tasks required . . . after MacRegen raised sufficient investment capital.” (Id. ¶¶ 18, 20.) “[T]hese

continued representations . . . motivated Dr. Burnette to continue performing services for more than 4 years.” (Id. ¶ 21.) However, MacRegen did not compensate Burnette for his work on these assignments. (Id. ¶ 18.) Instead, when he was terminated on December 21, 2018, MacRegen paid him 150,000 shares of its common stock. (Id. ¶¶ 19, 30.)

Burnette claims that MacRegen breached its agreements to pay him for the completion of additional assignments (Count I – Breach of Contract); in the alternative, Burnette performed these additional services, from which MacRegen derived substantial benefit, in the absence of a contract and expected to be compensated (Count II – Quantum Meruit); Burnette justifiably relied on representations by MacRegen that he would be compensated and was induced to

enter the Consulting Agreement and provide additional services (Count III – Negligent Misrepresentation); MacRegen knowingly made false statements about compensating Burnette to induce him to enter the Consulting Agreement and provide additional services (Count IV – Fraudulent Misrepresentation). MacRegen has moved to dismiss each of these claims.

II. To survive a motion to dismiss made pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure, a complaint “must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 570 (2007)). “A claim has facial plausibility when the

plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Id. (citing Twombly, 550 U.S. at 556); see also McCleary-Evans v. Md. Dep’t of Transp., State Highway Admin., 780 F.3d 582, 585 (4th Cir. 2015) (noting that a complaint must “contain[] sufficient factual matter, accepted as true, to state a

claim to relief that is plausible on its face in the sense that the complaint’s factual allegations must allow a court to draw the reasonable inference that the defendant is liable for the misconduct alleged”). However, when a complaint states facts that are “’merely consistent with’ a defendant’s liability, it ‘stops short of the line between possibility and plausibility of ‘entitlement to relief.’’” Iqbal, 556 U.S. at 678 (quoting Twombly, 550 U.S. at 557). When evaluating whether the complaint

states a claim that is plausible on its face, the facts are construed in the light most favorable to the plaintiff and all reasonable inferences are drawn in his favor. U.S. ex rel. Oberg v. Pa. Higher Educ. Assistance Agency, 745 F.3d 131, 136 (4th Cir. 2014). Nevertheless, “labels and conclusions[,]” “a formulaic recitation of the elements of a cause of action[,]” and “naked assertions . . . without some further

factual enhancement” are insufficient. Twombly, 550 U.S. at 557. In other words, “[f]actual allegations must be enough to raise a right to relief above the speculative level”. Id. at 555. Finally, a court can consider documents “attached to the complaint as exhibits.” Goines v. Valley Cmty. Servs. Bd., 822 F.3d 159, 166 (4th Cir. 2016) (citing Fed. R. Civ. P. 10(c)). A.

As an initial matter, it must be determined which state’s laws apply to each of these claims. A federal court with diversity jurisdiction applies the forum state’s choice-of-law rules. See Klaxon Co. v. Stentor Elec. Mfg. Co., 313 U.S. 487, 496 (1941). North Carolina courts hold “that where parties to a contract have agreed that a given jurisdiction’s substantive law shall govern the interpretation of the

contract, such a contractual provision will be given effect.” Tanglewood Land Co., Inc. v. Byrd, 261 S.E.2d 655, 656 (N.C. 1980). However, “[t]he law of the state chosen” will not apply if “the chosen state has no substantial relationship to the parties or the transaction and there is no other reasonable basis for the parties’ choice” or if the “application of the law of the chosen state would be contrary to a fundamental policy of a state which has a materially greater interest than the

Free access — add to your briefcase to read the full text and ask questions with AI

MACREGEN, INC. v. BURNETTE, (M.D.N.C. 2021).

MACREGEN, INC. v. BURNETTE (MACREGEN, INC. v. BURNETTE) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Klaxon Co. v. Stentor Electric Manufacturing Co.
313 U.S. 487 (Supreme Court, 1941)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Jenkins v. Akzo Noble Coatings, Inc.
35 F. App'x 79 (Fourth Circuit, 2002)
Baltimore County MD v. Cigna Healthcare
238 F. App'x 914 (Fourth Circuit, 2007)
Cozzarelli v. Inspire Pharmaceuticals Inc.
549 F.3d 618 (Fourth Circuit, 2008)
Raritan River Steel Co. v. Cherry, Bekaert & Holland
367 S.E.2d 609 (Supreme Court of North Carolina, 1988)
Tanglewood Land Co., Inc. v. Byrd
261 S.E.2d 655 (Supreme Court of North Carolina, 1980)
Taylor v. Gore
588 S.E.2d 51 (Court of Appeals of North Carolina, 2003)
Cable Tel Services, Inc. v. Overland Contracting, Inc.
574 S.E.2d 31 (Court of Appeals of North Carolina, 2002)
Hudgins v. Wagoner
694 S.E.2d 436 (Court of Appeals of North Carolina, 2010)
Wing v. Town of Landis
599 S.E.2d 431 (Court of Appeals of North Carolina, 2004)
Coley v. North Carolina National Bank
254 S.E.2d 217 (Court of Appeals of North Carolina, 1979)
Driver v. Burlington Aviation, Inc.
430 S.E.2d 476 (Court of Appeals of North Carolina, 1993)
Petrosky v. Peterson
859 A.2d 77 (Supreme Court of Delaware, 2004)
TSC RESEARCH, LLC v. Bayer Chemicals Corp.
552 F. Supp. 2d 534 (M.D. North Carolina, 2008)
Nahigian v. Juno Loudoun, LLC
684 F. Supp. 2d 731 (E.D. Virginia, 2010)
Kuroda v. SPJS Holdings, L.L.C.
971 A.2d 872 (Court of Chancery of Delaware, 2009)